(MENAFN- GlobeNewsWire - Nasdaq) Wireless, AI-enabled Holter monitors gain traction as cardiovascular disease, preventive care, telemedicine and demand for continuous home monitoring drive adoptionDublin, Sept. 30, 2026 (GLOBE NEWSWIRE) -- "Global Cardiac Holter Monitor Market Report by Product Type, Lead Type, End User, Countries and Company Analysis 2026-2034" has been added to ResearchAndMarkets.com's offering.
The global cardiac Holter monitor market is projected to grow from US$ 712.34 million in 2025 to US$ 1.61 billion by 2034, registering a Compound Annual Growth Rate (CAGR) of 9.53% from 2026 to 2034. Market expansion is supported by the increasing prevalence of cardiovascular diseases, stronger demand for continuous cardiac monitoring, growing adoption of preventive healthcare, and technological advances in wearable and wireless medical devices.
Cardiac Holter Monitor Market Growth Drivers
Cardiovascular disorders, including arrhythmias, atrial fibrillation, and coronary heart disease, are becoming more prevalent due to aging populations, inactive lifestyles, unhealthy diets, obesity, and elevated stress levels. World Health Organization data indicated that approximately 1.28 billion adults aged 30-79 years had high blood pressure in 2021, with most cases concentrated in low-and middle-income countries. Rising obesity rates are also increasing the risk of atrial fibrillation and related cardiac conditions.
Holter monitoring supports the identification of intermittent cardiac abnormalities that may not appear during shorter diagnostic tests. As healthcare providers place greater emphasis on early diagnosis and preventive cardiology, hospitals, diagnostic centers, and cardiac clinics are increasing their use of continuous heart monitoring systems.
Wearable, Wireless, and Connected Monitoring Technologies
Technological innovation is reshaping the cardiac Holter monitor market. Modern devices are becoming smaller, lighter, more comfortable, and capable of recording data for longer periods. Wireless connectivity, cloud platforms, artificial intelligence, advanced sensors, and improved battery performance enable more efficient data collection and clinical analysis.
Connected cardiac monitoring systems also support remote patient management through mobile applications and cloud infrastructure. This capability aligns with the expansion of telemedicine, home healthcare, and out-patient services. In January 2024, iRhythm Technologies received CE certification for its Zio monitor and ZEUS System under EU MDR requirements. During the same month, Medtronic and Cardiac Design Labs introduced Padma Rhythms heart monitoring technology in India.
Preventive Healthcare and Home Cardiac Monitoring
Demand for home monitoring is increasing as patients and healthcare professionals seek earlier identification of heart rhythm disorders while reducing hospital visits and treatment costs. Older adults and patients requiring extended observation are supporting adoption of portable cardiac Holter monitors across home care environments.
Healthcare organizations are also shifting suitable diagnostic procedures away from conventional inpatient settings. This transition is creating opportunities for wearable monitoring patches, wireless devices, remote cardiac services, and software platforms that give clinicians access to patient information regardless of location.
Market Challenges
The high cost of advanced cardiac Holter monitors remains a significant barrier, particularly for smaller clinics and healthcare systems in developing economies. Devices equipped with wireless connectivity, AI-driven analysis, and cloud storage can require substantial investment. Software maintenance, equipment updates, cybersecurity measures, and long-term data storage add to the total cost of ownership.
Data privacy and regulatory compliance present additional challenges. Connected devices collect and transmit sensitive patient information, increasing the need for secure platforms and effective protection against cyber attacks. Manufacturers must also navigate different medical device approval procedures, clinical requirements, and healthcare standards across international markets.
Product and Technology Outlook
Wireless cardiac Holter monitors are expected to record strong demand because they offer greater patient mobility and facilitate remote clinical oversight. Integration with Bluetooth, Internet of Things (IoT), artificial intelligence, mobile applications, and cloud systems is improving monitoring efficiency across hospitals, clinics, and home healthcare settings.
Cardiac Holter monitor software is another important growth area. AI and machine learning tools can assist clinicians with ECG data analysis, arrhythmia identification, reporting, and integration with electronic medical records. The growing use of telecardiology and digital healthcare systems is further strengthening demand for software-based cardiac diagnostics.
2-channel cardiac Holter monitors remain widely used for routine and cost-efficient cardiac assessment. Their portability, affordability, and improving reliability support adoption in clinical settings and developing markets where complex multi-channel systems may not be required.
End User Outlook
Hospitals represent a major end user segment because of their substantial cardiac patient volumes, access to cardiologists, and investment in advanced diagnostic infrastructure. Integration between cardiac monitoring systems and hospital information platforms is improving data storage, analysis, and clinical reporting. Ambulatory Surgical Centers and other outpatient facilities are also expanding their use of portable monitoring technologies.
Regional Market Highlights
The United States cardiac Holter monitor market benefits from established healthcare infrastructure, favorable reimbursement conditions, high cardiovascular disease prevalence, and rapid adoption of wearable and AI-based monitoring. In March 2024, Wellysis and Artella Solutions announced remote cardiac monitoring services in the country.
Germany is supported by an aging population, preventive healthcare programs, strong reimbursement policies, and continued investment in medical innovation. In January 2024, Biotronik introduced a new generation of cardiac monitoring wearables designed to improve ECG accuracy outside hospitals and enhance patient comfort.
India is experiencing rapid market development due to rising cases of high blood pressure, arrhythmias, and lifestyle-related heart disease. Expanding diagnostic infrastructure, improved awareness, and demand for affordable portable devices are supporting adoption in urban and semi-urban areas. In June 2024, AliveCor India launched a personal ECG monitoring device featuring artificial intelligence capabilities for smartphone-based heart screening.
Saudi Arabia is also expected to register growth as obesity, inactivity, and an aging population contribute to cardiovascular risk. Government investment in healthcare modernization, digital health services, and remote monitoring is improving access to cardiac diagnostics. In September 2023, Seha Virtual Hospital launched a remote cardiac monitoring service using wearable Holter monitors.
Key Cardiac Holter Monitor Companies
General Electric Company (GE) Nihon Kohden Corporation Hill-Rom Holdings, Inc. OSI Systems, Inc. Boston Scientific Corporation Koninklijke Philips N.V. Medtronic plc Irhythm Technologies Inc.
Company coverage includes business overviews, key personnel, recent developments, SWOT analysis, and revenue analysis. Competitive activity is expected to focus on connected monitoring platforms, diagnostic accuracy, patient comfort, cybersecurity, regulatory compliance, and expansion into remote cardiac care.
Key Attributes:
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment